PPAR Activation and Decreased Proliferation in Oral Carcinoma Cells With 4-HPR

PPAR γ activation represents a novel target for anti-cancer therapy for head and neck cancer and the current level of clinical toxicity of 4-HPR would be judged acceptable to utilize this agent alone or in combination chemotherapy.